General situation of development of biological products manufacturing industry

Our country's biological products industry has entered the period of rapid development since 1980s, has maintained a rapid development momentum: the average annual growth rate remained at more than 25%. Industry has begun to take shape, in 2010 China's biological products production enterprises have 867, industrial output value of 134645000000 yuan (including the traditional biological industry and modern biological industry). However, the biological products industry is still in the initial stage, especially in the emerging field of tissue engineering, genome research and post genome research. The degree of industrialization is not high, not showing significant economic benefits, but the changes brought by this technology will change the life and survival of human society, it has huge economic benefits, and has broad prospects for development. These enterprises are mainly distributed in some economically developed provinces, cities and economic development zones, such as Beijing, Shanghai, Guangdong, Zhejiang, Jiangsu, Jilin, Shandong, Liaoning, etc.. On the whole, the overall characteristics of the bio engineering enterprises are: the investment is very small, but the absolute output is very small, R & D enterprises or R & D and R & D enterprises are more; some enterprises and traditional pharmaceutical (chemical synthesis, fermentation, etc.) mixed production.